SCHEMBL6829318

SCHEMBL6829318

CC1(C)OC[C@H](Cn2ccc3cc(N)ccc32)O1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
PRKCI P41743 1/20 0.40
KDM4E B2RXH2 1/20 0.40
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TMEM97 Q5BJF2 2/20 0.37
SIGMAR1 Q99720 2/20 0.37
NTSR1 P30989 1/20 0.36
PLK4 O00444 1/20 0.35
FLT4 P35916 1/20 0.35
KDR P35968 1/20 0.35
TEK Q02763 1/20 0.35
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
KMT2A Q03164 1/20 0.33
CA2 P00918 2/20 0.33
EGFR P00533 1/20 0.32
HTR2A P28223 4/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30083347 1.00 ALDH1A1 (0.43) ALDH1A1NPSR1PRKCIKDM4EHPGD
SCHEMBL6829321 1.00 ALDH1A1 (0.43) ALDH1A1NPSR1PRKCIKDM4EHPGD
SCHEMBL849259 0.85 HTR2A (0.45) ALDH1A1NPSR1KDM4EHPGDTSHR
SCHEMBL849258 0.85 HTR2A (0.45) ALDH1A1NPSR1KDM4EHPGDTSHR
SCHEMBL3016774 0.82 ALDH1A1 (0.46) ALDH1A1NPSR1TSHRTMEM97SIGMAR1
SCHEMBL15709956 0.80 ALDH1A1 (0.50) ALDH1A1NPSR1KDM4EHPGDTSHR
SCHEMBL15243998 0.80 ALDH1A1 (0.50) ALDH1A1NPSR1KDM4EHPGDTSHR
SCHEMBL15244603 0.80 ALDH1A1 (0.50) ALDH1A1NPSR1KDM4EHPGDTSHR
SCHEMBL1466010 0.76 ALDH1A1 (0.41) ALDH1A1NPSR1KDM4EHPGDTSHR
SCHEMBL1466008 0.76 ALDH1A1 (0.41) ALDH1A1NPSR1KDM4EHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004046118-A2 2-4-(DI-PHENYL-AMINO)-PYRIMIDINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2004-06-03 WO disclosed